Bioform Medical Inc (Other) (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Expires: January 31, 2008 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

VERON INTERNATIONAL LTD

2. Date of Event Requiring Statement (MM/DD/YYYY) 11/6/2007

3. Issuer Name and Ticker or Trading Symbol

BIOFORM MEDICAL INC [BFRM]

(Last) (First) (Middle)

TOP FLOOR, CHINACHEM GOLDEN PLAZA, 77 MODY ROAD, TSIMSHATSUI EAST

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director ___ X ___ 10% Owner
_____ Officer (give title below) _____ Other (specify below)

(Street)

KOWLOON, K3

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	160550	D ⁽¹⁾

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Series A Convertible Preferred Stock	⁽²⁾	⁽³⁾	Common Stock	1000000	⁽²⁾	D ⁽¹⁾
Series B Convertible Preferred Stock	⁽²⁾	⁽³⁾	Common Stock	1757789	⁽²⁾	D ⁽¹⁾
Series C Convertible Preferred Stock	⁽²⁾	⁽³⁾	Common Stock	392000	⁽²⁾	D ⁽¹⁾

Explanation of Responses:
( 1)	The shares are held directly by Veron International Limited. Mr. Leung and Mr. Chan share voting investment decision with respect to these shares but Mr. Leung and Mr. Chan each disclaim beneficial ownership of these shares.
( 2)	The reported securities are convertible at any time at the option of Veron International Limited, but automatically convert into shares of Common Stock on a 1-for-1 basis immediately prior to the closing of the Issuer's initial public offering, estimated to be on or about November 13, 2007.
( 3)	Not applicable.

Remarks:
The Date of Event is based upon the date of effectiveness of the Issuer's Registration Statement on Form S-1 filed in connection with the Issuer's initial public offering, estimated to be on or about November 6, 2007.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
VERON INTERNATIONAL LTD TOP FLOOR, CHINACHEM GOLDEN PLAZA 77 MODY ROAD, TSIMSHATSUI EAST KOWLOON, K3		X
Leung Joseph Wing Kong TOP FLOOR, CHINACHEM GOLDEN PLAZA 77 MODY ROAD, TSIMSHATSUI EAST KOWLOON, K3		X
Chan Kam Por TOP FLOOR, CHINACHEM GOLDEN PLAZA 77 MODY ROAD, TSIMSHATSUI EAST KOWLOON, K3		X

Signatures
/s/ Joseph Wing Kong Leung, as board member of Veron International Limited		11/2/2007
^** Signature of Reporting Person		Date
/s/ Joseph Wing Kong Leung		11/2/2007
^** Signature of Reporting Person		Date
/s/ Kam Por Chan		11/2/2007
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.